DNA-Guided Precision Medicine for Cancer: A Case of Irrational Exuberance?
- PMID: 26851184
- DOI: 10.1158/2159-8290.CD-15-1321
DNA-Guided Precision Medicine for Cancer: A Case of Irrational Exuberance?
Abstract
Precision treatment with targeted cancer drugs requires the selection of patients who are most likely to benefit from a given therapy. We argue here that the use of a combination of both DNA and transcriptome analyses will significantly improve drug response prediction.
©2016 American Association for Cancer Research.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources